Mgr. Martin Hrubý, Ph.D., DSc
Major collaborations
- Tumor Immunology Department, Radboud University, Nijmegen, Netherlands (Professor C. Figdor, anticancer immunotherapeutics, common H2020 joint project PRECIOUS EU.2.1.2. 686089)
- Supramolecular Chemistry Group, Ghent University, Ghent, Belgium (professor R. Hoogenboom, polyoxazolines)
- Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden – Rossendorf, Germany (Dr. H. Stephan and Dr. M. Kubeil, polymer metal chelators for cancer treatment)
- Institute for energy technology, Oslo, Norway (Dr. Sindre Hassfjell, 161Tb radiopharmaceuticals, international project ELECTTRA)
- Department of Chemistry, University of Oslo, Oslo, Norway (Prof. Bo Nystrom, antituberculotic nanoparticles with rifampicin)
- University of Minnesota, Minneapolis, U.S.A. (Prof. Timothy P. Lodge group, pH- and thermoresponsive polymers).
- University of Hefei, Hefei, China (Prof. Chi Wu, light- and thermoresponsive polymers)
- Universidade do ABC, Sao Paolo, Brazil (Prof. Fernando Giacomelli, soft matter)
- CEA Saclay, Saclay, France (Dr. Edmond Gravel and Dr. Eric Doris, ROS-responsive nanoparticles)
- Center of Advanced Preclinical Imaging, First Medical Faculty, Charles University in Prague, Czech Republic, Prague (Dr. Luděk Šefc, medical imaging and testing our polymers)
- Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University in Olomouc, Olomouc, CZ (Dr. M. Petřík, Dr. P. Džubák, Dr. M. Hajdúch, anticancer radiopharmaceuticals, the international infrastructure EATRIS)
- Institute of Organic Chemistry and Biochemistry CAS, Prague (Dr. P. Cígler, Dr. P. Šácha, Prof. J. Konvalinka – polymer GCPII inhibitors, fluorescent nanodiamonds)
